Data obtained by CTV News from Health Canada shows that 85 per cent of inspections of drug manufacturing sites supplying the ...

An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.

Bayer files elinzanetant as a non-hormonal treatment for menopausal symptoms, with Astellas' first-to-market Veozah in its sights ...